OFORMA Trademark

Trademark Overview

On Thursday, October 21, 2004, a trademark application was filed for OFORMA with the United States Patent and Trademark Office. The USPTO has given the OFORMA trademark a serial number of 78503696. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, June 21, 2006. This trademark is owned by Pfizer Inc.. The OFORMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; central nervous system and neurological diseases and disorders; urological and urogenital diseases and disorders; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders; migraines, pain, hypertension, inflammation and inflammatory diseases and disorders; metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; and hemolytic diseases and disorders; pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations; smoking cessation preparations, tissue and skin repair preparations and gynecological preparations
oforma

General Information

Serial Number78503696
Word MarkOFORMA
Filing DateThursday, October 21, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, June 21, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases and disorders; central nervous system and neurological diseases and disorders; urological and urogenital diseases and disorders; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders; migraines, pain, hypertension, inflammation and inflammatory diseases and disorders; metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; and hemolytic diseases and disorders; pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations; smoking cessation preparations, tissue and skin repair preparations and gynecological preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 28, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Wednesday, August 23, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, August 23, 2006ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 20, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 27, 2005PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2005NOTICE OF PUBLICATION
Wednesday, June 1, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 27, 2005ASSIGNED TO LIE
Wednesday, May 25, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2005ASSIGNED TO EXAMINER
Thursday, October 28, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

oforma disorders diseases preparations pharmaceutical sexual dysfunction namely erectile hemolytic diabetes